Company intelligence / Profile preview

Sushma

Zirakpur, Punjab, India

Ownership: Private
Development stage: Other

Overview

Sushma Biotech is an Indian pharmaceutical company founded in 2018 that specializes in providing high-quality, affordable healthcare products. The company operates in the PCD (Propaganda Cum Distribution) franchise and third-party contract manufacturing sectors, utilizing WHO-GMP and GLP-certified production facilities. Its diverse product portfolio includes capsules, dry syrups, injections, powders, suspensions, syrups, and tablets distributed across a robust PAN-India network. Sushma Biotech focuses on collaborative partnerships and reliable logistics to ensure timely delivery and accessibility of essential medicines throughout India.

Therapeutic areas: ImmunologyNeurologyInfectious DiseasesCardiovascularEndocrinology
Modalities: Small molecule
Industry: Pharma

Drug pipeline

1 asset

ULTRAPROT-DHA

Unknown

Beyond the preview

Go deeper on Sushma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sushma.

Explore the full profile